Cargando…

Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy

OBJECTIVES: To assess the predictive and prognostic value of changes in longitudinal neutrophile-to-lymphocyte (NLR) ratios in men receiving taxane-based chemotherapy for metastatic prostate cancer (PC). METHODS: Retrospective, unicentric cohort study of patients treated with either docetaxel for me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuberger, Manuel, Weiß, Christel, Goly, Nora, Skladny, Janina, Nitschke, Katja, Wessels, Frederik, Kowalewski, Karl F., Waldbillig, Frank, Hartung, Friedrich, Nientiedt, Malin, Egen, Luisa, Herrmann, Jonas, Jarczyk, Jonas, Walach, Margarete Teresa, Kriegmair, Maximilian C., Westhoff, Niklas, Worst, Thomas S., Nuhn, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755453/ https://www.ncbi.nlm.nih.gov/pubmed/36522513 http://dx.doi.org/10.1007/s12672-022-00603-0

Ejemplares similares

Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort
por: Neuberger, Manuel, et al.
Publicado: (2022)

Radiomics in Renal Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mühlbauer, Julia, et al.
Publicado: (2021)

An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq
por: Waldbillig, Frank, et al.
Publicado: (2023)

A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma
por: Wessels, Frederik, et al.
Publicado: (2023)

Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
por: Waldbillig, Frank, et al.
Publicado: (2020)

Peritoneal flap for lymphocele prophylaxis following robotic-assisted laparoscopic radical prostatectomy with pelvic lymph node dissection: study protocol and trial update for the randomized controlled PELYCAN study
por: Neuberger, M., et al.
Publicado: (2021)

ROBOCOP II (ROBOtic assisted versus conventional open partial nephrectomy) randomised, controlled feasibility trial: clinical trial protocol
por: Kowalewski, Karl-Friedrich, et al.
Publicado: (2021)

The comprehensive complication index (CCI): proposal of a new reporting standard for complications in major urological surgery
por: Kowalewski, K. F., et al.
Publicado: (2020)

Deep learning can predict survival directly from histology in clear cell renal cell carcinoma
por: Wessels, Frederik, et al.
Publicado: (2022)

Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder
por: Koch, Jonas, et al.
Publicado: (2023)

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy
por: Herrmann, Jonas, et al.
Publicado: (2021)

Lipopolysaccharide Tolerance in Human Primary Monocytes and Polarized Macrophages
por: Li, Hui, et al.
Publicado: (2023)

Validation of a German translation of the CARE questionnaire and its implementation as electronic PROM to assess patient-reported postoperative convalescence and recovery after major urological surgery
por: Wessels, Frederik, et al.
Publicado: (2021)

Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy
por: Walach, Margarete Teresa, et al.
Publicado: (2023)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Nientiedt, Cathleen, et al.
Publicado: (2017)

The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro
por: Erb, Ulrike, et al.
Publicado: (2020)

Treatment decision satisfaction and regret after focal HIFU for localized prostate cancer
por: Westhoff, Niklas, et al.
Publicado: (2020)

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer
por: Wu, Sheng, et al.
Publicado: (2020)

Framework for a living systematic review and meta-analysis for the surgical treatment of bladder cancer: introducing EVIglance to urology
por: Wieland, Victoria L.S., et al.
Publicado: (2023)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications
por: Wenzel, Mike, et al.
Publicado: (2021)

miR-10a-5p and miR-29b-3p as Extracellular Vesicle-Associated Prostate Cancer Detection Markers
por: Worst, Thomas Stefan, et al.
Publicado: (2019)

Frailty predicts outcome of partial nephrectomy and guides treatment decision towards active surveillance and tumor ablation
por: Walach, M. T., et al.
Publicado: (2021)

P-gp and taxanes
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2014)

Mechanisms of Taxane Resistance
por: Maloney, Sara M., et al.
Publicado: (2020)

CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
por: Langebäck, Anette, et al.
Publicado: (2019)

Ex vivo validation of a real-time multispectral endoscopic system for the detection and biopsy of bladder tumors
por: Grüne, Britta, et al.
Publicado: (2021)

Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
por: Anoop, T M, et al.
Publicado: (2022)

Neoadjuvant chemotherapy outcome with taxane-based versus non-taxane protocols in gastric cancer
por: Kianersi, Shirin, et al.
Publicado: (2023)

The EEF1A2 gene expression as risk predictor in localized prostate cancer
por: Worst, Thomas Stefan, et al.
Publicado: (2017)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Sex Differences in Taxane Toxicities
por: Chmielewski, Nicole N., et al.
Publicado: (2022)

The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma
por: Porubsky, Stefan, et al.
Publicado: (2021)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
por: Sikic, Danijel, et al.
Publicado: (2020)

Docetaxel: an alternative taxane in ovarian cancer
por: Katsumata, N
Publicado: (2003)

Disposition Kinetics of Taxanes in Peritoneal Dissemination
por: Miyamoto, Ken'ichi, et al.
Publicado: (2012)

Scalable, enantioselective taxane total synthesis
por: Mendoza, Abraham, et al.
Publicado: (2011)

Taxanes for the Treatment of Metastatic Breast Cancer
por: Gradishar, W.J.
Publicado: (2012)

Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gpepd77an7ldgp0i6nbgvlq28v